SODIUM 2-(5-(1-(3-METHYL-1,3-THIAZOLIDIN-2-YLIDENE)PROPAN-2-YLIDENE)-4-OXO-2-SULFANYLIDENE-1,3-THIAZOLIDIN-3-YL)ACETATE
UNII NM6W268MDQ
Substance Identification & Data
This profile provides standardized clinical and technical data for Sodium 2-(5-(1-(3-methyl-1,3-thiazolidin-2-ylidene)propan-2-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NM6W268MDQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 144940-73-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C12H13N2O3S3.Na PKVRQWIDQPNCPF-UOJASKDKSA-M Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Sodium 2-(5-(1-(3-methyl-1,3-thiazolidin-2-ylidene)propan-2-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.